Literature DB >> 29155418

ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells.

H M Jeong, J Han, S H Lee, H-J Park, H J Lee, J-S Choi, Y M Lee, Y-L Choi, Y K Shin, M J Kwon.   

Abstract

This corrects the article DOI: 10.1038/oncsis.2017.87.

Entities:  

Year:  2017        PMID: 29155418      PMCID: PMC5824018          DOI: 10.1038/oncsis.2017.89

Source DB:  PubMed          Journal:  Oncogenesis        ISSN: 2157-9024            Impact factor:   7.485


Correction to: Oncogenesis (2017) 6, e389; doi:10.1038/oncsis.2017.87; Published online 9 October 2017 The legend of Figure 5 was published incorrectly. The correct legend should read as follows: Figure 5. Association between ESRP1 gene expression and OS or PFS in patients with ovarian serous adenocarcinoma. (a, b) Kaplan–Meier plot of 5-year OS, and PFS in total primary tumors and (c, d) stage III primary tumors. Patients were divided into two groups based on ESRP1 expression, ESRP1 low expression (ESRP1-low) and ESRP1 high expression (ESRP1-high) groups. The statistical difference in the survival between the two groups was tested with the log-rank test. The number of patients for each group is provided in parentheses. This error has now been rectified and the corrected article appears in this issue together with this corrigendum. The publishers wish to apologise for any inconvenience caused.
  11 in total

1.  Development and validation of novel prognostic models based on RNA-binding proteins in breast cancer.

Authors:  Wei Fan; Jun Ding; Shushu Liu; Wei Zhong
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

2.  APC regulation of ESRP1 and p120-catenin isoforms in colorectal cancer cells.

Authors:  Maree C Faux; Lauren E King; Serena R Kane; Christopher Love; Oliver M Sieber; Antony W Burgess
Journal:  Mol Biol Cell       Date:  2020-11-25       Impact factor: 4.138

3.  Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines.

Authors:  Thiemo F Dinger; Oleg Chen; Claudia Dittfeld; Lydia Hetze; Melanie Hüther; Marit Wondrak; Steffen Löck; Wolfgang Eicheler; Georg Breier; Leoni A Kunz-Schughart
Journal:  Theranostics       Date:  2020-06-18       Impact factor: 11.556

4.  Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.

Authors:  Samuel E Harvey; Yilin Xu; Xiaodan Lin; Xin D Gao; Yushan Qiu; Jaegyoon Ahn; Xinshu Xiao; Chonghui Cheng
Journal:  RNA       Date:  2018-07-24       Impact factor: 4.942

5.  Circ-NOLC1 promotes epithelial ovarian cancer tumorigenesis and progression by binding ESRP1 and modulating CDK1 and RhoA expression.

Authors:  Shuo Chen; Wu Wu; Qian-Hui Li; Bu-Min Xie; Fan Shen; Yu-Ping Du; Zhi-Hong Zong; Li-Li Wang; Xiao-Qing Wei; Yang Zhao
Journal:  Cell Death Discov       Date:  2021-01-22

6.  Identification of an RNA binding protein-related gene signature in hepatocellular carcinoma patients.

Authors:  Li Wang; Na Zhou; Jialin Qu; Man Jiang; Xiaochun Zhang
Journal:  Mol Med       Date:  2020-12-09       Impact factor: 6.354

7.  Proteomics-Based Evidence for a Pro-Oncogenic Role of ESRP1 in Human Colorectal Cancer Cells.

Authors:  Ugo Ala; Marta Manco; Giorgia Mandili; Emanuela Tolosano; Francesco Novelli; Paolo Provero; Fiorella Altruda; Sharmila Fagoonee
Journal:  Int J Mol Sci       Date:  2020-01-16       Impact factor: 5.923

8.  Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis.

Authors:  Chang-Mei Weng; Qing Li; Kui-Jun Chen; Cheng-Xiong Xu; Meng-Sheng Deng; Tao Li; Dong-Dong Zhang; Zhao-Xia Duan; Zhi-Qiang Chen; Guan-Hua Li; Jing Chen; Jian-Min Wang
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

9.  Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma.

Authors:  Wei Li; Li-Na Gao; Pei-Pei Song; Chong-Ge You
Journal:  Aging (Albany NY)       Date:  2020-02-22       Impact factor: 5.682

10.  Modelling the developmental spliceosomal craniofacial disorder Burn-McKeown syndrome using induced pluripotent stem cells.

Authors:  Katherine A Wood; Charlie F Rowlands; Huw B Thomas; Steven Woods; Julieta O'Flaherty; Sofia Douzgou; Susan J Kimber; William G Newman; Raymond T O'Keefe
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.